Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis

Comparative outcomes of HBV-infected compensated cirrhosis with low-level viremia (LLV) versus maintained virological response (MVR) are unclear. We conducted a large, multiethnic, multicenter study to examine the natural history of LLV versus MVR in compensated cirrhosis. We enrolled patients with...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Hepatology (Baltimore, Md.) Md.), 2023-05, Vol.77 (5), p.1746-1756
Hauptverfasser:	Huang, Daniel Q, Tamaki, Nobuharu, Lee, Hyung Woong, Park, Soo Young, Lee, Yu Rim, Lee, Hye Won, Lim, Seng Gee, Lim, Tae Seop, Kurosaki, Masayuki, Marusawa, Hiroyuki, Mashiba, Toshie, Kondo, Masahiko, Uchida, Yasushi, Kobashi, Haruhiko, Furuta, Koichiro, Izumi, Namiki, Kim, Beom Kyung, Sinn, Dong Hyun
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral Agents - therapeutic use Carcinoma, Hepatocellular - drug therapy DNA, Viral Hepatitis B virus - genetics Humans Liver Cirrhosis - epidemiology Liver Neoplasms - drug therapy Viremia - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!